摘要
目的 :探讨肺炎支原体感染诱发儿童哮喘的治疗。方法 :对 12 0例肺炎支原体感染诱发的儿童哮喘随机分 2组 ,治疗组 6 0例应用红霉素、糖皮质激素、β2 受体兴奋剂治疗 ;对照组 6 0例应用糖皮质激素、β2 受体兴奋剂治疗 ,比较两组疗效及哮喘复发率。结果 :两组近期疗效相同 ,复发率治疗组为 16 .7% ,对照组为 10 0 % ,两组比较 χ2 =12 0 ,P <0 .0 1。结论 :应用红霉素控制或消除肺炎支原体感染是治疗的关键 ,不一定长期应用糖皮质激素及平喘药治疗。
Objective:To evaluate the therapy for asthma in children caused by mycoplasma pneumoniae(MP) infection Methods:120 cases of asthma caused by MP infection were devided into groups randomly 60 Patients in study group were treated with erythromycin,corticosteroids and β 2 agonist,while 60 patients in control group were treated with corticosteroids and β 2 agonist only.Effects to the different kinds of therapy and the recurrent rate of the two groups were analyzed Result:short term effect of both groups revealed no difference The recurrent rate in the study group was 16 7%,and 100% in the control group(χ 2=120,P<0 01) Conclusion:In patients of asthma caused by MP infection,erythromycin is the key in the treatment Long term use of corticosteroids and bronchodilator might not be necessary
出处
《广西医学》
CAS
2001年第3期458-459,共2页
Guangxi Medical Journal
